The purpose of this study is to evaluate the behavioral and physiological effects of
buprenorphine and naloxone, both alone and in combination.
Please contact site for information.
Principal InvestigatorCharles O'Brien, M.D., Ph.D.PDVAMC Treatment Research Center
Philadelphia, Pennsylvania 19104United StatesThere is no listed contact information for this specific location.Site Status: N/A
| All trademarks are property of their legal owners. | All Rights Reserved
ClinicalConnection.com is a resource that provides information on clinical trials conducted worldwide.
ClinicalConnection.com does not conduct or endorse clinical trials. Please consult your physician before participating.
© All Rights Reserved.
Terms of Service